← FDA DRUG APPROVALS

FDA ANDA · ANDA203374

CARISOPRODOL

Sponsor: SCIEGEN PHARMS

APPLICATION
ANDA203374
TYPE
ANDA
ORIGINAL APPROVAL
2014-01-27
LATEST ACTION
2019-04-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CARISOPRODOLPrescription
CARISOPRODOL 350MG · TABLET · ORAL

Approval history

2019-04-02Labeling · Supplement 12 · standardAP
2014-01-27UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →